F Caputo Selected Research

F Caputo Research Topics

9	Alcoholism (Alcohol Abuse) 11/2017 - 01/2000
4	Neoplasms (Cancer) 10/2020 - 05/2005
2	Heroin Dependence (Heroin Abuse) 11/2009 - 03/2002
2	Breast Neoplasms (Breast Cancer) 06/2006 - 05/2005
1	COVID-19 06/2021
1	Fibrosis (Cirrhosis) 04/2012
1	Infections 04/2012
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2010
1	Cocaine-Related Disorders (Cocaine Addiction) 11/2009
1	Liver Failure 06/2009
1	Hypertrophy 06/2009
1	Neoplasm Metastasis (Metastasis) 06/2009
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2008
1	Disease Progression 05/2005
1	Substance-Related Disorders (Drug Abuse) 04/2000
1	Poisoning 04/2000
1	Paralysis (Palsy) 04/2000
1	Alcohol-Related Disorders 01/2000

6	Pharmaceutical PreparationsIBA 10/2020 - 01/2000
3	4-hydroxybutyric acidIBA 11/2009 - 04/2000
2	Baclofen FDA LinkGeneric 04/2012 - 01/2000
2	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 11/2009 - 03/2002
2	Heroin (Diamorphine)IBA 11/2009 - 03/2002
2	Methadone (Dolophine)FDA LinkGeneric 11/2009 - 03/2002
1	RNA (Ribonucleic Acid)IBA 06/2021
1	LipidsIBA 06/2021
1	VaccinesIBA 06/2021
1	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 04/2015
1	GABA-B Receptor AgonistsIBA 04/2012
1	Formaldehyde (Formol)FDA Link 01/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2008
1	Ifosfamide FDA LinkGeneric 04/2008
1	Gemcitabine FDA Link 04/2008
1	ErbB Receptors (EGF Receptor)IBA 06/2006
1	Tyrosine Kinase InhibitorsIBA 06/2006
1	Docetaxel (Taxotere)FDA Link 06/2006
1	Gefitinib (Iressa)FDA Link 06/2006
1	taxaneIBA 05/2005
1	Trastuzumab (Herceptin)FDA Link 05/2005
1	Opioid Analgesics (Opioids)IBA 03/2002
1	Local AnestheticsIBA 04/2000
1	Biomarkers (Surrogate Marker)IBA 01/2000

4	Therapeutics 06/2006 - 04/2000
3	Drug Therapy (Chemotherapy) 04/2012 - 09/2002
1	Oral Diagnosis (Oral Examination) 11/2017
1	Hepatectomy 06/2009
1	Secondary Prevention 09/2002
1	Nerve Block (Nerve Blocks) 04/2000
1	Brachial Plexus Block 04/2000